Published in J Pathol on January 01, 2015
Characterization of the immune response in ganglia after primary simian varicella virus infection. J Neurovirol (2015) 0.76
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
The complete DNA sequence of varicella-zoster virus. J Gen Virol (1986) 16.00
RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science (1987) 11.14
THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med (1965) 10.85
Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol (2009) 6.62
MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature (2008) 5.29
Varicella. Lancet (2006) 4.47
Recommendations for the management of herpes zoster. Clin Infect Dis (2007) 4.33
Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network. J Virol (1994) 3.72
Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci U S A (1988) 3.49
Live vaccine used to prevent the spread of varicella in children in hospital. Lancet (1974) 3.24
Satellite glial cells in sensory ganglia: from form to function. Brain Res Brain Res Rev (2005) 3.12
Varicella: report of two fatal cases with necropsy, virus isolation, and serologic studies. Am J Pathol (1957) 3.02
Topics in herpesvirus genomics and evolution. Virus Res (2006) 2.84
The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J Virol (1992) 2.80
Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med (1990) 2.75
The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med (1991) 2.62
The etiologic agents of varicella and herpes zoster; isolation, propagation, and cultural characteristics in vitro. J Exp Med (1958) 2.62
Immune responses to varicella-zoster in the aged. Arch Intern Med (1982) 2.59
Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virol (1996) 2.41
Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia. J Virol (2006) 2.32
Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol (2003) 2.24
Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J Virol (2000) 2.23
Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci U S A (1998) 2.20
Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci U S A (2007) 2.13
Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung. J Exp Med (2012) 2.03
Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis (2003) 2.02
Giant cell formation in the tonsils in the prodromal stage of chickenpox: Report of a case. Am J Pathol (1939) 1.95
Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology (1980) 1.95
Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J Virol (1995) 1.89
Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci U S A (2005) 1.89
Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med (2004) 1.85
The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purified virus particles. J Virol (1995) 1.84
Varicella zoster virus in the temporal artery of a patient with giant cell arteritis. J Neurol Sci (2013) 1.83
Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans. PLoS Pathog (2009) 1.82
The cutaneous microcirculation. J Investig Dermatol Symp Proc (2000) 1.76
Herpes Zoster. Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J Neurol Sci (1972) 1.76
Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes (2001) 1.75
Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis (1986) 1.72
Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics (1981) 1.69
Characterization of viremia at different stages of varicella-zoster virus infection. J Med Virol (1998) 1.68
The DNA sequence of the simian varicella virus genome. Virology (2001) 1.67
Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin. Proc Natl Acad Sci U S A (1995) 1.60
Recent studies on the isolation and characterization of Delta herpesvirus. Lab Anim Sci (1974) 1.54
Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. J Virol (2002) 1.53
Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell (2006) 1.51
Varicella-zoster virus transcriptome in latently infected human ganglia. J Virol (2010) 1.51
Concern Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology (2014) 1.50
Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J Virol (2000) 1.46
Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis (2011) 1.45
Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell (2004) 1.45
Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis (1985) 1.44
Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J Infect Dis (1991) 1.43
Characterization of the putative protein kinases specified by varicella-zoster virus genes 47 and 66. J Gen Virol (1994) 1.40
Airborne transmission of chickenpox in a hospital. N Engl J Med (1980) 1.39
The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J Virol (2009) 1.38
Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc Natl Acad Sci U S A (2009) 1.37
Alveolar macrophages transport pathogens to lung draining lymph nodes. J Immunol (2009) 1.33
Varicella zoster virus (VZV) infects and establishes latency in enteric neurons. J Neurovirol (2011) 1.28
Central nervous system manifestations of chickenpox. Can Med Assoc J (1970) 1.28
Viremia is present in incubation period in nonimmunocompromised children with varicella. J Pediatr (1985) 1.28
Neuronal localization of simian varicella virus DNA in ganglia of naturally infected African green monkeys. Virus Genes (2004) 1.26
The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study. PLoS One (2013) 1.25
Disseminated simian varicella virus infection in an irradiated rhesus macaque (Macaca mulatta). J Virol (2006) 1.24
Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol (2014) 1.22
A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe (2012) 1.21
Varicella zoster virus infection of highly pure terminally differentiated human neurons. J Neurovirol (2012) 1.20
Viremic phase in nonimmunocompromised children with varicella. J Pediatr (1984) 1.19
Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans Am Clin Climatol Assoc (2012) 1.18
Simian varicella virus reactivation in cynomolgus monkeys. Virology (2007) 1.18
Varicella-Zoster virus IE63, a major viral latency protein, is required to inhibit the alpha interferon-induced antiviral response. J Virol (2007) 1.18
Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis (2011) 1.17
Pangaea and the Out-of-Africa Model of Varicella-Zoster Virus Evolution and Phylogeography. J Virol (2012) 1.17
Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis. Proc Natl Acad Sci U S A (2011) 1.16
A varicella-like disease in macaque monkeys. J Infect Dis (1973) 1.16
Latent simian varicella virus reactivates in monkeys treated with tacrolimus with or without exposure to irradiation. J Neurovirol (2010) 1.16
Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host. J Virol (2001) 1.15
The Histology of the Skin Lesions in Varicella. J Med Res (1906) 1.15
A virus disease of captive vervet monkeys (Cercopithecus aethiops) caused by a new herpesvirus. Arch Gesamte Virusforsch (1967) 1.13
Update on varicella zoster virus vasculopathy. Curr Infect Dis Rep (2014) 1.12
Configuration of latent varicella-zoster virus DNA. J Virol (1995) 1.12
Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J Infect Dis (1992) 1.12
Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death. J Virol (2012) 1.12
Virus infections of the eye. Rev Med Virol (1998) 1.11
Simian varicella virus DNA in dorsal root ganglia. Proc Natl Acad Sci U S A (1991) 1.11
Perspectives on vaccines against varicella-zoster virus infections. Curr Top Microbiol Immunol (2010) 1.11
Varicella and herpes zoster: a perspective and overview. J Infect Dis (1992) 1.10
RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation. PLoS Pathog (2014) 1.10
Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus. PLoS Pathog (2011) 1.10
Pathology of the human spinal ganglia in varicella-zoster virus infection. Acta Neuropathol (1975) 1.08
Palaeontological evidence for an Oligocene divergence between Old World monkeys and apes. Nature (2013) 1.06
Exanthematous disease in patas monkeys caused by a herpes virus. Lancet (1968) 1.06
Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection. PLoS One (2012) 1.05
Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia. J Virol (2003) 1.05
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. J Infect Dis (2013) 2.19
Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis. J Infect Dis (2009) 1.25
Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis. J Infect Dis (2008) 1.24
Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues. J Infect Dis (2009) 1.23
IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J Immunol (2002) 1.19
Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. J Clin Invest (2012) 1.16
Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death. J Virol (2012) 1.12
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain (2009) 1.09
Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia. PLoS Pathog (2013) 1.01
Neuron-interacting satellite glial cells in human trigeminal ganglia have an APC phenotype. J Immunol (2009) 0.98
T-cell immunity to human alphaherpesviruses. Curr Opin Virol (2013) 0.98
T-cell infiltration correlates with CXCL10 expression in ganglia of cynomolgus macaques with reactivated simian varicella virus. J Virol (2012) 0.97
No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis. J Clin Virol (2010) 0.95
Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes. J Med Virol (2004) 0.94
Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals. J Infect Dis (2012) 0.93
Prevalence of human Herpesviridae in cerebrospinal fluid of patients with multiple sclerosis and noninfectious neurological disease in the Netherlands. J Neurovirol (2014) 0.93
T-Cell tropism of simian varicella virus during primary infection. PLoS Pathog (2013) 0.92
Monitoring the inflammatory process in herpetic stromal keratitis: the role of in vivo confocal microscopy. Ophthalmology (2012) 0.90
Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK. Invest Ophthalmol Vis Sci (2007) 0.89
Flt3 ligand expands lymphoid progenitors prior to recovery of thymopoiesis and accelerates T cell reconstitution after bone marrow transplantation. J Immunol (2007) 0.88
Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Invest Ophthalmol Vis Sci (2002) 0.87
HSV neutralization by the microbicidal candidate C5A. PLoS One (2011) 0.87
High incidence of genotypic variance between sequential herpes simplex virus type 2 isolates from HIV-1-seropositive patients with recurrent genital herpes. J Infect Dis (2006) 0.85
Simian varicella virus infection of Chinese rhesus macaques produces ganglionic infection in the absence of rash. J Neurovirol (2012) 0.85
Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection. J Virol (2013) 0.85
Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV. J Med Virol (2013) 0.85
Detection of Circovirus in Foxes with Meningoencephalitis, United Kingdom, 2009-2013. Emerg Infect Dis (2015) 0.85
Ocular infections in sub-Saharan Africa in the context of high HIV prevalence. Trop Med Int Health (2014) 0.84
Restricted T cell receptor beta-chain variable region protein use by cornea-derived CD4+ and CD8+ herpes simplex virus-specific T cells in patients with herpetic stromal keratitis. J Infect Dis (2003) 0.84
Immunohistochemical detection of intra-neuronal VZV proteins in snap-frozen human ganglia is confounded by antibodies directed against blood group A1-associated antigens. J Neurovirol (2012) 0.84
High prevalence of anelloviruses in vitreous fluid of children with seasonal hyperacute panuveitis. J Infect Dis (2012) 0.83
Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients. J Clin Virol (2013) 0.82
Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis. Invest Ophthalmol Vis Sci (2007) 0.81
Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients. J Med Virol (2012) 0.80
Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells. J Immunol (2014) 0.80
Human ocular-derived virus-specific CD4+ T cells control varicella zoster virus replication in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2008) 0.78
Zipper cell endotheliopathy: a new subset of idiopathic corneal edema. Ophthalmology (2010) 0.78
Characterization of the varicella zoster virus (VZV)-specific intra-ocular T-cell response in patients with VZV-induced uveitis. Exp Eye Res (2006) 0.77
Herpes simplex virus infection of the human eye induces a compartmentalized virus-specific B cell response. J Infect Dis (2002) 0.76
In vitro and in vivo replication of seal gammaherpesviruses in cells of multiple species. Microbes Infect (2006) 0.76
Norovirus Infection in Harbor Porpoises. Emerg Infect Dis (2017) 0.75
Good visual outcome of tuberculous chorioretinitis after ART initiation in a HIV-infected patient. Int Ophthalmol (2014) 0.75